<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) are highly effective in reducing mortality related to <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, there is considerable morbidity associated with their use, mostly related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, the occurrence of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks in patients with <z:hpo ids='HP_0001635'>heart failure</z:hpo> is associated with an adverse prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>Strategies to reduce or prevent <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and shocks are a prime area of focus and development in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> </plain></SENT>
</text></document>